RADIONUCLIDE SPECT BONE SCAN

DATE: 10/11/2005

PROCEDURE:  Following IV administration of technetium 99m methylenediphosphonate, SPECT imaging was performed of the following area (s).

AREA/VIEWS: Lumbar vertebrae, coronal, sagittal and transverse views.

RADIOPHARMACEUTICAL DOSE:  [25]  mCi

CLINICAL HISTORY: The patient is a [...]-year-old [fe]male with a history of [...]. The patient is referred for evaluation of possible osseous metastatic disease.

CORRELATIVE STUDIES: None.

COMPARISON: None.

FINDINGS:    There is increased tracer activity observed in [...] that are all consistent with degenerative changes.  The remainder of the axial and appendicular skeleton demonstrates normal tracer uptake. There is normal tracer activity in both kidneys and in the urinary bladder.

CONCLUSIONS:

There are no significant changes when compared to the prior study.

Normal study showing no evidence of osseous metastatic disease.

Thank you for referring this patient to the UCLA Nuclear Medicine Clinic.

I, [...], M.D., Ph.D., have reviewed this Nuclear Medicine study personally, and am in full agreement with the findings of the report presented here.